Lumanity Medical Strategy & Communications’ Post

I've never enjoyed my job more than I do right now - it's such an exciting time in medicines development! In this report, we summarise our key takeaways of where we believe we are now and where we hope to go in patient engagement.

Discussions in the industry are progressing from ‘why’ to ‘how’ to ‘now’ when involving patients in clinical research design. Our experts have identified some key themes that emerged from both the US and European Patients as Partners in Clinical Research conferences, that took place in March and May respectively. Some of these trends and themes include: - More consistent and earlier approach to patient focused drug development (PFDD) - Equitable access to research including health literacy and diversity, equity and inclusion - Measuring impact of patient engagement in research - Improving the sponsor, site and study participant partnership - Participant data release in clinical trials - Compensation for study participants Read the full report to access our key themes and reflections at https://buff.ly/3XPY7uj #PatientsasPartners #ClinicalResearch #PFDD #patientengagement #medcomms #healthliteracy #patients

Understanding the patient perspective and incorporating the patient voice is essential to creating more impactful communications programs and Lumanity's expert patient patient strategy team have collected insights and key themes from the US and European Patients as Partners in Clinical Research conferences that took place earlier this year and published at the link below! If you want to know more about how we can support you in developing concrete patient strategies and programmes, please reach out...!

Discussions in the industry are progressing from ‘why’ to ‘how’ to ‘now’ when involving patients in clinical research design. Our experts have identified some key themes that emerged from both the US and European Patients as Partners in Clinical Research conferences, that took place in March and May respectively. Some of these trends and themes include: - More consistent and earlier approach to patient focused drug development (PFDD) - Equitable access to research including health literacy and diversity, equity and inclusion - Measuring impact of patient engagement in research - Improving the sponsor, site and study participant partnership - Participant data release in clinical trials - Compensation for study participants Read the full report to access our key themes and reflections at https://buff.ly/4cjprFI #PatientsasPartners #ClinicalResearch #PFDD #patientengagement #medcomms #healthliteracy #patients

The FDA recently released draft guidance on Diversity Action Plans, a monumental step towards inclusivity in clinical research! The draft guidance outlines the requirements for sponsors to submit Diversity Action Plans, aiming to increase the enrollment of underrepresented groups in clinical trials. This initiative emphasizes the importance of including diverse populations to improve the generalizability and effectiveness of clinical study results. Key Highlights: 🔹 Detailed goals for enrollment disaggregated by race, ethnicity, sex, and age group. 🔹 Rationale for these goals based on disease prevalence and potential differential responses. 🔹 Comprehensive strategies to achieve these enrollment goals, including community engagement and culturally competent practices. At PEP!IN, we are already prepared to help sponsors navigate these new requirements. Our services are designed to ensure compliance while enhancing patient engagement and retention through: - Culturally competent outreach and support. - Patient matching and recruitment services. - Continuous monitoring and reporting to meet FDA guidelines. - Community Outreach Programs. - Patient Education and Awareness Campaigns. - Cultural Competency Training for clinical staff. - Patient Support Services, including logistical support like transportation and flexible scheduling. - Partnerships with Community Organizations to improve outreach and trust. Let’s work together to make clinical trials more inclusive and effective for everyone. Discover how PEP!IN can support your Diversity Action Plan and engagement initiatives by scheduling a consultation today by visiting www.WeArePEPIN.com or emailing us at contact@wearepepin.com. #ClinicalTrials #DiversityInResearch #FDAUpdates #InclusiveScience #PEPIN

May 20 - International Clinical Trials Day International Clinical Trials Day is an opportunity to appreciate the role played by clinical trials in the context of scientific research, by ensuring access to innovative medicines and promoting public health. Clinical trials are an essential component of medical research, providing a solid foundation for the development of innovative treatments and medicines. These studies allow the safety and effectiveness of new therapies to be tested, as well as the identification of risk factors and ways to prevent disease. They contribute to improving the quality of life of patients and advancing the healthcare system by providing relevant data and information. https://lnkd.in/dHfM9V34

Clinical Trials Day, celebrated on May 20th, recognizes the contributions of the clinical research professionals who work tirelessly to advance medical science. It’s also a day to honor those who conduct and participate in clinical trials, which are vital for developing new treatments and improving outcomes for our patients. Read on to learn about the many ways our FINISHCANCER team is helping to shape the future of healthcare. https://lnkd.in/giHkjc8N #ClinicalTrialsDay #NationalCancerResearchMonth

Clinical Trials Day, celebrated on May 20th, recognizes the contributions of the clinical research professionals who work tirelessly to advance medical science. It’s also a day to honor those who conduct and participate in clinical trials, which are vital for developing new treatments and improving outcomes for our patients. Read on to learn about the many ways our FINISHCANCER team is helping to shape the future of healthcare. https://lnkd.in/giHkjc8N #ClinicalTrialsDay #NationalCancerResearchMonth

Celebrating Innovation and Dedication on Clinical Trials Day 2024 🎉 Today, we honour the incredible contributions of clinical researchers and participants around the world on Clinical Trials Day. Their unwavering commitment to advancing medicine has played a pivotal role in enhancing healthcare for us all ❗ Clinical trials are the backbone of medical progress, providing us with valuable insights and leading to breakthroughs that save lives. The journey from the laboratory 🔬 to the patient’s bedside 🛏 is long and complex, but it’s through the dedication of countless individuals that we can turn possibilities into realities. Here are some impactful statistics that highlight the significance of clinical trials: ✔ The Association of Clinical Research Professionals (ACRP) has more than 16,500 members globally, representing a diverse and dedicated workforce. ✔ Clinical Trials Day is a tradition since 2014, celebrating the achievements and progress made through clinical research. ✔ The 2024 theme, “Trailblazers Among Us,” emphasizes the relentless pursuit of knowledge and the exacting application of best practices by clinical research professionals. Let’s take a moment to appreciate the hard work, innovation, and collaboration that go into every study. It’s through these efforts that we can look forward to a healthier future for everyone. 🙏 Thank you to all the researchers, healthcare professionals, and trial participants who make this possible. Your work does not go unnoticed, and the impact of your contributions will be felt for generations to come. #WeAreIQVIA #ClinicalTrialsDay #cFSPCares #SMSupports #HealthcareHeroes If you'd like to explore more about clinical trial conducted at IQVIA click on the link!

Ensuring Access Beyond Trials: A Framework for Continued Care    Post-trial responsibilities are a critical aspect of ethical clinical research, particularly when it comes to continued access to investigational medicines. The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) Center is proud to provide a Framework for Post-Trial Continued Access to Investigational Medicines to guide sponsors, researchers, and stakeholders in navigating these complex responsibilities.    This comprehensive resource complements our foundational Principles on Post-Trial Responsibilities by offering actionable guidance on:    ✅ Identifying and addressing potential barriers to continued access.  ✅ Clarifying roles and responsibilities for stakeholders.  ✅ Developing equitable and sustainable approaches to ensure participant care.    Together, these tools aim to foster trust, transparency, and ethical stewardship in clinical trials, ensuring participants are supported beyond the study’s conclusion.    Explore the framework and join us in advancing participant-centered research: Framework for Post-Trial Continued Access to Investigational Medicines: https://lnkd.in/eCAE6GMz    #ClinicalResearch #EthicalResearch #ParticipantAdvocacy #PostTrialAccess #MRCTCenter